Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 1:05 AM
Ignite Modification Date: 2025-12-25 @ 1:05 AM
NCT ID: NCT03989193
Eligibility Criteria: Inclusion Criteria: * Patients with thin maxillary ridge of 3 to 5 mm thickness of crestal alveolar bone (horizontal deficiency). * Patients with free medical history and adequate proper oral hygiene. * Patients of adequate alveolar bone height. * Both genders males and females will be included. Exclusion Criteria: * General contraindications to implant surgery. * Subjected to irradiation in the head and neck area less than 1 year before implantation. * Untreated periodontitis. * Poor oral hygiene and motivation. * Uncontrolled diabetes. * Pregnant or nursing. * Substance abuse. * Psychiatric problems or unrealistic expectations. * Severe bruxism or clenching. * Immunosuppressed or immunocompromised. * Treated or under treatment with intravenous amino-bisphosphonates. * Lack of opposite occluding dentition/prosthesis in the area intended for implant placement. * Active infection or severe inflammation in the area intended for implant placement. * Need of bone augmentation procedures at implant placement. * Unable to open mouth sufficiently to accommodate the surgical tooling. * any 'complex case' if implants had to be placed in the aesthetic zone defined as second to second maxillary premolars. * Patients participating in other studies, if the present protocol could not be properly followed. * Requiring only single implant-supported crowns.
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 58 Years
Study: NCT03989193
Study Brief:
Protocol Section: NCT03989193